[ Price : $8.95]
Upsher-Smith adds an open-label extension study to PREVAIL, a global Phase 3 trial for USL255 (extended-release topiramate), indic...[ Price : $8.95]
CDER issues its annual report for FY 2009 highlighting its work on the pandemic flu.[ Price : $8.95]
The Plasma Protein Therapeutics Association urges FDA to exclude plasma-derived therapies and their recombinant DNA technology ana...[ Price : $8.95]
FDAs New England District Office warns Sepal Reproductive Devices about multiple regulatory violations.[ Price : $8.95]
Attorney Arnold Friede says FDAs Warning Letter on Increlex professional promotional materials gives insight into the agencys defi...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to amend its regulations on health warning on cigarette packages and ads to implement...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on Medical Devices; Device Tracking 21 CFR Part 821.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on how to improve a Dear Health Care Provider letter to communicate importa...